No Data
Express News | Sera Prognostics Announces Publication Of AVERT PRETERM TRIAL Results In Peer-Reviewed Journal, Diagnostics
Sera Prognostics PreTRM Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
Sera Prognostics Announces Publication of Positive AVERT PRETERM TRIAL Results in the International Peer-Reviewed Journal, DiagnosticsSALT LAKE CITY, July 9, 2024 /PRNewswire/ -- Sera Prognostics Inc.
Sera Prognostics Joins Russell 2000, 3000 Indexes; Shares Rise
Sera Prognostics (SERA) said Monday it joined the Russell 2000 and Russell 3000 indexes, effective immediately. Membership in the US all-cap Russell 3000 index is for one year and means automatic incl
SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION
SALT LAKE CITY, July 1, 2024 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker
Sera Prognostics President Evguenia Lindgardt Sells 41% Of Holding
Anyone interested in Sera Prognostics, Inc. (NASDAQ:SERA) should probably be aware that the President, Evguenia Lindgardt, recently divested US$218k worth of shares in the company, at an average price
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
Sera Prognostics Inc., The Pregnancy Company (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...
全力買い : Do you have bio recommendations?